These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31668192)

  • 1. Antibiotic-Resistant Community-Acquired Bacterial Pneumonia.
    Ho J; Ip M
    Infect Dis Clin North Am; 2019 Dec; 33(4):1087-1103. PubMed ID: 31668192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program.
    Gordon KA; Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2003 Aug; 46(4):285-9. PubMed ID: 12944021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-Acquired Pneumonia in the Asia-Pacific Region.
    Song JH; Huh K; Chung DR
    Semin Respir Crit Care Med; 2016 Dec; 37(6):839-854. PubMed ID: 27960208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating paediatric community-acquired pneumonia in the era of antimicrobial resistance.
    Galli L; Montagnani C; Chiappini E; de Martino M
    Acta Paediatr; 2013 Dec; 102(465):25-33. PubMed ID: 24330270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic susceptibility in relation to genotype of Streptococcus pneumoniae, Haemophilus influenzae, and Mycoplasma pneumoniae responsible for community-acquired pneumonia in children.
    Morozumi M; Chiba N; Okada T; Sakata H; Matsubara K; Iwata S; Ubukata K
    J Infect Chemother; 2013 Jun; 19(3):432-40. PubMed ID: 23108427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern.
    File TM
    Am J Med; 2004 Aug; 117 Suppl 3A(3):39S-50S. PubMed ID: 15360096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hospitalist perspective on treatment of community-acquired bacterial pneumonia.
    Amin AN; Cerceo EA; Deitelzweig SB; Pile JC; Rosenberg DJ; Sherman BM
    Postgrad Med; 2014 Mar; 126(2):18-29. PubMed ID: 24685965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China.
    Tao LL; Hu BJ; He LX; Wei L; Xie HM; Wang BQ; Li HY; Chen XH; Zhou CM; Deng WW
    Chin Med J (Engl); 2012 Sep; 125(17):2967-72. PubMed ID: 22932165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia.
    Ohno A; Ishii Y; Kobayashi I; Yamaguchi K
    J Infect Chemother; 2007 Oct; 13(5):296-301. PubMed ID: 17982717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy].
    Uncu H; Colakoğlu S; Turunç T; Demiroğlu YZ; Arslan H
    Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
    Appelbaum PC; Gillespie SH; Burley CJ; Tillotson GS
    Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial pathogens of adult community-acquired pneumonia in Southern Estonia.
    Leesik H; Ani U; Juhani A; Altraja A
    Medicina (Kaunas); 2006; 42(5):384-94. PubMed ID: 16778466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review.
    Torres A; Blasi F; Peetermans WE; Viegi G; Welte T
    Eur J Clin Microbiol Infect Dis; 2014 Jul; 33(7):1065-79. PubMed ID: 24532008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae.
    Isozumi R; Yoshimine H; Morozumi M; Ubukata K; Ariyoshi K
    Respirology; 2009 Nov; 14(8):1206-8. PubMed ID: 19732389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory infections due to drug-resistant bacteria.
    Song JH; Chung DR
    Infect Dis Clin North Am; 2010 Sep; 24(3):639-53. PubMed ID: 20674796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worldwide guidelines for respiratory tract infections: community-acquired pneumonia.
    Dalhoff K
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S39-44. PubMed ID: 11574194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preventive measures for drug resistant bacteria by guidelines].
    Tomono K
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():531-3. PubMed ID: 17455675
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotic resistance: challenges and successes in respiratory infection.
    Sethi S; Bryan J
    Future Microbiol; 2016; 11(4):481-4. PubMed ID: 27081910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.